Data / Medical devices / France / Sebia
Sebia: FDA-registered device maker in EVRY Essonne, France, 38 510(k) clearances
Sebia is registered with the FDA (registration 8023024) in EVRY Essonne, France. It lists 28 device types. The FDA files 38 510(k) clearances under its listings, the newest dated April 4, 2024. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 8023024
- FEI number
- 6387
- Address
- Parc Technologique Leonard De Vinci, EVRY Essonne, France, 91008
- Owner or operator
- SEBIA (8023024)
- Roles
- Manufacturer
- First device listed
- May 24, 1995
- Registered through
- 2026
- Brand names listed
- CAPI 3 HEMOGLOBIN TERA, CAPI 3 HEMOGLOBIN OCTA, CAPI 3 NEONAT HB USING THE CAPILLARYS 3 DBS INSTRUMENT, CAPI3 HbA1c TERA, CAPI3 HbA1c OCTA, CAPILLARYS HB A1C USING CAPILLARYS 2 FLEX PIERCING, CAPILLARYS IMMUNOTYPING USING CAPILLARY 2 AND CAPILLARY 2 FLEX PIERCING, CAPILLARYS NEONAT HB, CAPi3 HbA1c, Capi 3 Immunotyping TERA, Capi 3 Immunotyping OCTA and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| April 4, 2024 | K232027 | CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| February 23, 2024 | K231601 | FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2 | DFH | Substantially Equivalent | Sebia | accessdata.fda.gov |
| November 18, 2022 | K210623 | FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2 | DFH | Substantially Equivalent | Sebia | accessdata.fda.gov |
| November 12, 2021 | K203184 | HYDRASHIFT 2/4 isatuximab | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| November 1, 2019 | K192095 | CAPI 3 Immunotyping, Capillarys 3 Tera | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| May 2, 2019 | K190851 | HYDRASHIFT 2/4 daratumumab | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| December 14, 2018 | K180762 | CAPI 3 HEMOGLOBIN(E) | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| February 7, 2018 | K171861 | CAPILLARYS Hb A1c | PDJ | Substantially Equivalent | Sebia | accessdata.fda.gov |
| January 11, 2018 | K172195 | HYDRASHIFT 2/4 daratumumab, daratumumab Control | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| September 12, 2017 | K171537 | CAPI 3 Hb A1c | PDJ | Substantially Equivalent | Sebia | accessdata.fda.gov |
| February 17, 2017 | K162281 | CAPI 3 Hb A1c, MULTI-SYSTEM Hb A1C CAPILLARY CONTROLS (2) | LCP | Substantially Equivalent | Sebia | accessdata.fda.gov |
| December 21, 2016 | K161928 | CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| January 8, 2015 | K143483 | MINICAP Immunotyping using the MINICAP and the MINICAP FLEX-PIERCING | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| March 28, 2014 | K133344 | MINICAP HB A1C, MINICAP FLEX-PIERCING, HB A1C CAPILLARYS CONTROLS, HBA1C CAPILLARYS CALIBRATORS | LCP | Substantially Equivalent | Sebia | accessdata.fda.gov |
| July 26, 2013 | K130500 | CAPILLARYS IMMUNOTYPING, CAPILLARYS 2 INSTRUMENT, IT/IF CONTROL, CAPILLARYS 2 FLEX PIERCING INSTRUMENT | CEF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| December 6, 2012 | K122101 | CAPILLARYS HEMOGLOBIN HBA1C CAPILLARYS 2 FLEX PIERCING CAPILLARYS HBA1C CONTROLS CAPILLARYS HBA1C C | LCP | Substantially Equivalent | Sebia | accessdata.fda.gov |
| May 25, 2012 | K112550 | CAPILLARYS HEMOGLOBIN, CAPILLARYS FLEX PIERCING SYSTEM | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| May 24, 2012 | K112491 | SEBIA CAPILLARYS HEMOGLOBIN(E) WITH CAPILLARYS 2 | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| November 7, 2011 | K101863 | IT/IF CONTROL | JJY | Substantially Equivalent | Sebia | accessdata.fda.gov |
| August 31, 2010 | K100307 | GELSCAN, MODEL 1206 | CFE | Substantially Equivalent | Sebia | accessdata.fda.gov |
| February 22, 2010 | K091283 | CAPILLARYS NEONAT HB (PN 2006) | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| April 14, 2009 | K082388 | MINICAP IMMUNOTYPING, MODEL: 2300 | CFF | Substantially Equivalent | Sebia | accessdata.fda.gov |
| March 26, 2009 | K082227 | MINICAP HEMOGLOBIN(E) KIT, MODEL 2207, 2227 | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| July 1, 2008 | K080916 | CAPILLARYS URINE | JKM | Substantially Equivalent | Sebia | accessdata.fda.gov |
| June 11, 2007 | K063498 | HYDRAGEL 18 A1AT ISOFOCUSING KIT (PN 4356) | OBZ | Substantially Equivalent | Sebia | accessdata.fda.gov |
| June 27, 2006 | K052291 | CAPILLARY'S HEMOGLOBIN(E) (PN 2007) | GKA | Substantially Equivalent | Sebia | accessdata.fda.gov |
| December 7, 2005 | K053031 | EXTENDSURE HBFASC CONTROL | JCM | Substantially Equivalent | Cantebury Scientific , Ltd. | accessdata.fda.gov |
| June 27, 2005 | K042939 | CAPILLARY'S IMMUNOTYPING (PN 2100) | DFH | Substantially Equivalent | Sebia, Inc. | accessdata.fda.gov |
| April 28, 2004 | K040925 | NORMAL AND HYPERGAMMA CONTROL SERUM | JJY | Substantially Equivalent | Sebia | accessdata.fda.gov |
| November 4, 2003 | K033277 | HYDRAGEL CSF ISOFOCUSING KITS | CFF | Substantially Equivalent | Morax | accessdata.fda.gov |
| June 13, 2001 | K011113 | HYDRAGEL ISO-PAL K20 (PN 3022); HYDRAGEL 7 ISO-PAL (PN 4112); HYDRAGEL 15 ISO-PAL (PN 4132) | CIN | Substantially Equivalent | Sebia | accessdata.fda.gov |
| December 29, 1999 | K992148 | HYDRAGEL-MINI ISO-CK KIT, HYDRAGEL ISO-CK KIT, HYDRAGEL 7 IS0-CK KIT, HYDRAGEL ISO-CK 15/30 KIT | CGS | Substantially Equivalent | Morax | accessdata.fda.gov |
| June 21, 1999 | K991362 | HYDRAGEL HEMOGLOBIN(E), MINI HEMOGLOBIN(E), 7 HEMOGLOBIN(E), 15 HEMOGLOBIN(E), ACID(E) HEMOGLOBIN(E), MINI ACID(E) HEMO) | JBD | Substantially Equivalent | Morax | accessdata.fda.gov |
| October 7, 1998 | K981048 | HYDRAGEL 6 CSF KIT | CFF | Substantially Equivalent | Morax | accessdata.fda.gov |
| March 4, 1998 | K972591 | HYDRAGEL BENCE JONES KIT/MAXI KIT HYDRAGEL BENCE JONES/HYDRAGEL 2/4 BENCE JONES KIT | JKM | Substantially Equivalent | Morax | accessdata.fda.gov |
| March 10, 1997 | K970477 | HYRAGEL ISO-LDH KIT/HYDRAGEL 15 ISO-LDH KIT | CFE | Substantially Equivalent | Sebia | accessdata.fda.gov |
| July 12, 1996 | K960669 | HYDRAGEL IF, 6 IF, 12 IF PENTA KITS/HYDRAGEL IF, DOUBLE IF, 2 IF, & 4 IF KITS | CFF | Substantially Equivalent | Morax | accessdata.fda.gov |
| December 4, 1986 | K863980 | U.S. DIAGNOSTICS ALKALINE PHOSPHATASE TEST | CJE | Substantially Equivalent | U. S. Diagnostics, Inc. | accessdata.fda.gov |
Compare with other makers
- All makers of Abnormal Hemoglobin Quantitation
- All makers of Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
- All makers of Lambda, Antigen, Antiserum, Control
- All makers of Kappa, Antigen, Antiserum, Control
- All makers of Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl
- All makers of Immunoelectrophoretic, Immunoglobulins, (G, A, M)
Updated April 4, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.